Editorial p2509 The Global Fund and the future of global health The Lancet + +... +

Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01726-X/fulltext?dgcid=raven_jbs_etoc_feature_lancet Nov 29, 2025 Volume 406Number 10519p2509-2600 https://www.thelancet.com/journals/lancet/issue/vol406no10519/PIIS0140-6736(25)X0048-9 Editorial p2509 The Global Fund and the future of global health The Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02421-3/fulltext?dgcid=raven_jbs_etoc_email